衰弱、实际年龄与COPD临床结局:全国性队列研究
该研究基于韩国国民健康保险数据库,纳入2010至2021年确诊COPD的40岁以上患者1,505,638例,用索赔衰弱指数分低、中、高衰弱,分析全因死亡与重度急性加重。中位随访7.0年,死亡500,097例、重度急性加重169,102例;衰弱与死亡及重度急性加重风险呈分级关联,且提供超出实际年龄的预后信息。
要点
- 衰弱程度越高,COPD患者全因死亡和重度急性加重风险越高。
- 衰弱提供独立于实际年龄的预后信息,应纳入风险评估。
- 高龄且低衰弱者预后相对较好,不宜仅凭年龄判断风险。
核心结论
- 在COPD患者中,衰弱风险提供超出实际年龄的预后信息,强调生物学脆弱性对结局的重要性。
研究设计与样本
- 全国性回顾性队列研究,使用韩国国民健康保险服务数据库。
- 纳入2010至2021年确诊COPD且年龄≥40岁患者1,505,638例。
- 衰弱用索赔衰弱指数评估并分为低、中、高三个等级。
- 主要结局为全因死亡,次要结局为重度急性加重。
- 采用多变量Cox比例风险模型估计风险比(HR)。
主要发现
- 中位随访7.0年(四分位距3.0-10.3),发生死亡500,097例、重度急性加重169,102例。
- 以≥70岁且低衰弱为参照,中年衰弱组死亡HR 1.19(95%CI 1.17-1.21),老年衰弱组HR 1.21(95%CI 1.20-1.21)。
- 高衰弱组死亡风险最高:<70岁HR 2.66(95%CI 2.54-2.78),≥70岁HR 1.90(95%CI 1.87-1.93)。
- 重度急性加重也观察到类似的衰弱分级关联。
临床怎么用
- 在COPD风险评估中应纳入衰弱评估,而不只依赖实际年龄。
- 对高衰弱患者应加强随访和急性加重预防管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Frailty and chronological age are major prognostic factors in chronic obstructive pulmonary disease (COPD), yet their combined effects have not been fully examined in large population-based cohorts. We investigated whether low frailty attenuates the adverse impact of aging on COPD outcomes. METHODS: We conducted a nationwide retrospective cohort study using the Korean National Health Insurance Service database. Patients aged ≥ 40 years diagnosed with COPD between 2010 and 2021 were included. Frailty was assessed using a claims-based frailty index and categorized as low, intermediate, or high. The primary outcome was all-cause mortality, and the secondary outcome was severe exacerbation. Multivariable Cox proportional hazards models were used to estimate hazard ratios (HRs). RESULTS: Among 1,505,638 patients with COPD, 784,962 were aged < 70 years and 720,676 were aged ≥ 70 years. Over a median follow-up of 7.0 years (interquartile range, 3.0-10.3), 500,097 deaths and 169,102 severe exacerbations occurred. Compared with older patients (≥ 70 years) with low frailty, intermediate frailty was associated with higher mortality risk in both younger (HR 1.19; 95% CI 1.17-1.21) and older patients (HR 1.21; 95% CI 1.20-1.21). High frailty showed highest risk (HR 2.66; 95% CI 2.54-2.78 in < 70 years; HR 1.90; 95% CI 1.87-1.93 in ≥ 70 years). Similar graded associations were observed for severe exacerbations. CONCLUSION: In patients with COPD, frailty risk provided prognostic information beyond chronological age, highlighting the importance of biological vulnerability in determining outcomes in COPD.
引用
- Kim T, Kim H, Choi S, et al. Frailty, Chronological Age, and Clinical Outcomes in COPD: A Nationwide Cohort Study. Respirology. 2026. PMID: 42816454. doi:10.1002/resp.70324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。